Start main page content

Q&A with Professor Shabir Madhi

Madhi is Professor of Vaccinology at Wits University, the Director of the South Africa Medical Research Council (SAMRC) Vaccines and Infectious Diseases Analytics Research Unit (VIDA), and leads the South African Ox1Cov-19 Vaccine VIDA-Trial.

Question: Why is there a need for a Covid 19 vaccine?
Question: Why do the trials in South Africa?
Question: Who developed, licensed and produces the vaccine?
When will the vaccine be available?
Question: Can you get infected with the Covid-19 vaccine?
Question: What are the timelines of the study and the development of the vaccine?
Question: What is the process of doing a clinical trial on a Covid 19 vaccine?
Question: Where do we stand in terms of a viable Covid 19 vaccine in SA?
Question: How are the participants selected for the study?
Question: How are the participants of the study protected?
Question: How are the participants of the study protected?
Question: Is this the new normal?
Question: Where do we stand in terms of a viable Covid 19 vaccine globally?
Question: How will the Covid 19 pandemic develop with or without the vaccine?
Question: What lessons can we learn from Covid 19?
Share